Release Date: 16/08/22 10:01 Summary: Capital Raising and Project Update Price Sensitive: Yes Download Document 713.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%